GALD
Galderma Group AG insider transactions
Healthcare · SIX · Switzerland
Net insider signal · last quarter
Buying
Share price & insider trades · last quarter ▲ buy ▼ sell
CHF 191.4 CHF 146.2 10 Apr 09 Jul
Insiders were net buyers over the last quarter — 3 buys against 2 sells — a net CHF 2.4M of buying. Most recent filing: 28 Apr 2026.
Net insider flow · last quarter
+CHF 2.4M 3 buys · 2 sells
Insider profiles
+●.●% avg 3m · win rate
Transactions
28 Apr 2026 Management Buy CHF 2,415,500 27 Apr 2026 Management Sell CHF 4,047,172 27 Apr 2026 Management Buy CHF 3,237,738
24 Apr 2026 Management ▼ Sell CHF 1,628,525
24 Apr 2026 Management ▲ Buy CHF 2,410,994
30 Mar 2026 Management ▲ Buy CHF 2,227,500
26 Mar 2026 Management ▼ Sell CHF 2,235,000
25 Mar 2026 Management ▼ Sell CHF 2,191,500
25 Mar 2026 Management ▲ Buy CHF 2,190,000
24 Mar 2026 Management ▼ Sell CHF 2,863,533
24 Mar 2026 Management ▲ Buy CHF 2,871,104
18 Mar 2026 Management ▼ Sell CHF 70,770
12 Mar 2026 Management ▼ Sell CHF 263,808
23 Dec 2025 Management ▼ Sell CHF 81,176
10 Dec 2025 Management ▼ Sell CHF 3,541,184
09 Dec 2025 Management ▼ Sell CHF 1,652,820
09 Dec 2025 Management ▼ Sell CHF 614,721
08 Dec 2025 Management ▼ Sell CHF 5,823,765
08 Dec 2025 Management ▼ Sell CHF 1,656,675
17 Sep 2025 Management ▼ Sell CHF 2,046,702
16 Sep 2025 Management ▼ Sell CHF 133,659
16 Sep 2025 Management ▼ Sell CHF 249,753
16 Sep 2025 Management ▼ Sell CHF 2,198,277
15 Sep 2025 Management ▼ Sell CHF 3,425,247
04 Sep 2025 Management ▼ Sell CHF 659,880
Showing older filings · the 3 most recent are subscriber-only
Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at Swiss-listed companies must disclose dealings in their company's shares to SIX. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.